NCT00563095Unknown不适用
A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Hepatocellular Carcinoma
Hospital Authority, Hong Kong1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2004年3月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- regression of tumour size
研究概览
简要总结
Primary: To compare the efficacy of TACE and TAIE.
Secondary: To compare the side effects of TACE and TAIE.
The outcome measurements include survival benefit and tumour regression induced by the two therapies.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Confirmed hepatocellular carcinoma not suitable for surgery
排除标准
- •Portal vein thrombosis
- •Severe arteriovenous shunt
- •Bilirubin level > 50 umol/mL
- •Prothrombin time > 5 seconds
结局指标
主要结局
regression of tumour size
时间窗: assessment every 6 months
次要结局
- side effects(every treatment given every 8 - 12 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular CarcinomaAdvanced Hepatocellular CarcinomaNCT02150317Eastern Hepatobiliary Surgery Hospital180
招募中
1 期
TACE Combined With PD-1 Knockout Engineered T Cell in Advanced Hepatocellular Carcinoma.Advanced Hepatocellular CarcinomaNCT04417764Central South University10
终止
不适用
TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic TherapyBleedingPeptic UlcerNCT00766961Chinese University of Hong Kong34
撤回
2 期
TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver CancerAdult Primary Hepatocellular CarcinomaRecurrent Adult Primary Liver CancerStage I Adult Primary Liver CancerStage II Adult Primary Liver CancerStage IIIA Adult Primary Liver CancerNCT02070419Case Comprehensive Cancer Center
进行中（未招募）
2 期
Study of TACE Combined With Camrelizumab in the Treatment of HCC PatientsHepatocellular CarcinomaNCT04483284Shanghai Zhongshan Hospital28